glp 1 for seniors Medicare GLP-1 Drug Coverage Discover Magazine | Learn more
Description
Treatment duration varies
In summary, GLP-1 RAs represent a promising therapeutic option for obese patients with HFpEF, but their large-scale adoption will require further evidence of efficacy, safety, and long-term benefits through rigorous and well-designed clinical trials
Yes, when prescribed by a provider for an appropriate indication
Do you have other conditions that may benefit from taking metformin or Wegovy
As a result, additional parameters indicative of weight loss efficacy were not included within the scope of this investigation
The FIGHT trial specifically evaluated using the GLP-1RAs, liraglutide, in patients with HF with reduced ejection fraction (HFrEF)
